SFM
NEOS

Systematic Financial Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Systematic Financial Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-30,855
Closed -$256K – 693
2018
Q1 		$256K Buy
30,855
+35
+0.1% +$334 0.01% 618
2017
Q4 		$314K Buy
+30,820
New +$296K 0.01% 605

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Systematic Financial Management's NEOS Position: Q2 2018 in Review

Systematic Financial Management sold out of Neos Therapeutics, Inc (NEOS) in Q2 2018, closing a stake of 30,855 shares — an estimated $256K sold.

Systematic Financial Management first reported a position in NEOS in Q4 2017 and held it in 2 quarters. The position peaked at $314K in Q4 2017. 73 funds tracked by Wall St. Rank hold NEOS as of Q2 2018.

  • Systematic Financial Management reported no remaining Neos Therapeutics, Inc position as of Q2 2018 after selling out during the quarter.
  • Systematic Financial Management sold 30,855 Neos Therapeutics, Inc shares in Q2 2018, an estimated $256K.
  • Systematic Financial Management first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 2 quarters.
  • Systematic Financial Management's Neos Therapeutics, Inc position peaked at $314K in Q4 2017.
  • 73 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2018.

Based on Systematic Financial Management's 13F filing for Q2 2018, filed 8 Aug 2018.